Orbit develop and apply innovative drug discovery platforms defined by a unique peptide display engine that deliver novel, functional, biologically relevant peptide therapeutic leads
Peptide leads are key starting points for the development of peptide, peptidomimetic and small molecule therapeutics as well as bioconjugates for cell targeting and cargo delivery
We offer services for the high throughput screening of chemical space and perform affinity screening and functional screening using both bead based technologies and microfuidics.
Orbits mission is to offer our Partners solutions to identify therapeutic candidates by adopting high throughput affinity and functional screening.
A bead based peptide display engine allows for faster peptide discovery by binding affinity
The ability to display high peptide copy number allows discovery of functional peptides in primary screens
The Orbit platform is target agnostic giving access to cell surface receptors, notably GPCRs and ion channels
The Orbit platform can distinguish a response from single cells
Use of Microfluidics to Miniaturise library production and cellular screening
Establishing a new standard
Orbit works with both industry and academic Partners to identify hits for existing and novel drug targets where therapeutic peptides can establish a new standard of care.